Each tablet contains Abiraterone Acetate USP 250mg Tablet.
Publish Date:
24-Jan-2024
Introducton:
Abiraterone Acetate is indicated in combination
with Prednisone for the treatment of patients with
Metastatic castration-resistant prostate cancer (CRPC)
Metastatic high-risk
castration-sensitive prostate cancer (CSPC)
